|
Hernandez-Silva D, Canton-Sandoval J, Martinez-Navarro FJ, Perez-Sanchez H, de Oliveira S, Mulero V, Alcaraz-Perez F, Cayuela ML. Senescence-Independent Anti-Inflammatory Activity of the Senolytic Drugs Dasatinib, Navitoclax, and Venetoclax in Zebrafish Models of Chronic Inflammation. Int J Mol Sci. 2022 Sep 9;23(18):10468. doi: 10.3390/ijms231810468. PubMed PMID: 36142384; PubMed Central PMCID: PMC9499634.
AÑO: 2022; IF: 5.6
|
36142384
|
Hernandez-Silva D, Alcaraz-Perez F, Perez-Sanchez H, Cayuela ML. Virtual screening and zebrafish models in tandem, for drug discovery and development. Expert Opin Drug Discov. 2023 Jul-Dec;18(8):903-915. doi: 10.1080/17460441.2022.2147503. Epub 2022 Nov 30. PubMed PMID: 36383405.
AÑO: 2023; IF: 6.0
|
|
Martinez-Balsalobre E, Garcia-Castillo J, Garcia-Moreno D, Naranjo-Sanchez E, Fernandez-Lajarin M, Blasco MA, Alcaraz-Perez F, Mulero V, Cayuela ML. Telomerase RNA-based aptamers restore defective myelopoiesis in congenital neutropenic syndromes. Nat Commun. 2023 Sep 22;14(1):5912. doi: 10.1038/s41467-023-41472-7. PubMed PMID: 37737237; PubMed Central PMCID: PMC10516865.
AÑO: 2023; IF: 14.7
|
|
Martinez-Lopez A, Tyrkalska SD, Alcaraz-Perez F, Cabas I, Candel S, Martinez Morcillo FJ, Sepulcre MP, Garcia-Moreno D, Cayuela ML, Mulero V. Evolution of LPS recognition and signaling: The bony fish perspective. Dev Comp Immunol. 2023 Aug;145:104710. doi: 10.1016/j.dci.2023.104710. Epub 2023 Apr 18. PubMed PMID: 37080369.
AÑO: 2023; IF: 2.7
|